Understanding how a bacteria affects the immune response in scrub typhus
Orientia tsutsugamushi Ank-host interactions in scrub typhus pathogenesis
This study is looking at how a germ called Orientia tsutsugamushi interacts with our immune system when someone has scrub typhus, with the goal of understanding how it makes us sick and finding better ways to treat it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-11009950 on NIH RePORTER |
What this research studies
This research investigates the interactions between the bacterium Orientia tsutsugamushi and the host's immune system in the context of scrub typhus, a serious infectious disease. The study focuses on how specific proteins produced by the bacterium can manipulate host immune responses, potentially leading to severe health complications. By examining these interactions, researchers aim to uncover the mechanisms that allow the bacterium to survive and cause disease, which could inform future treatment strategies. The approach involves detailed molecular analysis and screening of bacterial proteins that affect immune pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with scrub typhus or those at high risk of infection.
Not a fit: Patients who do not have scrub typhus or are not at risk of infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating scrub typhus and improving patient outcomes.
How similar studies have performed: Previous research has shown success in understanding host-pathogen interactions in other infectious diseases, suggesting potential for breakthroughs in this area as well.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Carlyon, Jason a — Virginia Commonwealth University
- Study coordinator: Carlyon, Jason a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.